Spectral Medical Inc.
EDTXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $675 | $813 | $572 | $645 |
| % Growth | -17% | 42.1% | -11.3% | – |
| Cost of Goods Sold | $191 | $291 | $125 | $274 |
| Gross Profit | $484 | $522 | $447 | $371 |
| % Margin | 71.7% | 64.2% | 78.1% | 57.5% |
| R&D Expenses | $0 | $1,842 | $0 | $0 |
| G&A Expenses | $2,946 | $2,757 | $3,741 | $2,697 |
| SG&A Expenses | $2,946 | $2,757 | $3,741 | $2,697 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $672 | -$1,582 | $247 | $217 |
| Operating Expenses | $3,618 | $3,017 | $3,988 | $2,914 |
| Operating Income | -$3,134 | -$2,495 | -$3,541 | -$2,543 |
| % Margin | -464.3% | -306.9% | -619.1% | -394.3% |
| Other Income/Exp. Net | -$27,182 | $562 | -$9,061 | $5,701 |
| Pre-Tax Income | -$30,316 | -$1,933 | -$12,602 | $3,158 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30,316 | -$1,933 | -$12,605 | $3,154 |
| % Margin | -4,491.3% | -237.8% | -2,203.7% | 489% |
| EPS | -0.11 | -0.007 | -0.044 | 0.011 |
| % Growth | -1,517.6% | 84.7% | -492% | – |
| EPS Diluted | -0.11 | -0.007 | -0.044 | 0.011 |
| Weighted Avg Shares Out | 286,966 | 284,906 | 284,760 | 280,049 |
| Weighted Avg Shares Out Dil | 286,966 | 284,906 | 284,760 | 280,049 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,364 | $1,175 | $1,083 | $999 |
| Depreciation & Amortization | $69 | $57 | $60 | $61 |
| EBITDA | -$28,883 | -$701 | -$11,459 | $4,218 |
| % Margin | -4,279% | -86.2% | -2,003.3% | 654% |